Currently Viewing
CURE New Issue Alert: 2019 Hematology Special Issue
September 25, 2019 – Katie Kosko and Jessica Skarzynski
Survey Shows Lung Cancer Stigma Has Decreased, More Awareness Still Needed
September 24, 2019 – Kristie L. Kahl
Expert Offers Advice for Women With Ovarian Cancer
September 24, 2019 – Kristie L. Kahl
What Women Should Know About the FDA's Endometrial Cancer Combination Approval
September 23, 2019 – Kristie L. Kahl
Join the Next #CureConnect Tweet Chat on Living With Cancer
September 23, 2019 – Jessica Skarzynski
Preventing Lymphedema: What Patients Need to Know
September 23, 2019 – Pat Whitworth, MD
Prostate Cancer Awareness Month: What You Need to Know
September 23, 2019 – Jessica Skarzynski
Thyroid Cancer Awareness Month: What You Need to Know
September 21, 2019 – Jessica Skarzynski
What Men Should Know About the FDA's Approval of Erleada
September 20, 2019 – Kristie L. Kahl

CURE New Issue Alert: 2019 Hematology Special Issue

Here’s a look at what’s inside our 2019 Hematology special issue.
BY Katie Kosko and Jessica Skarzynski
PUBLISHED September 25, 2019
Here’s a look at what’s inside our 2019 Hematology special issue:



It was once considered an incurable cancer, but thanks to a slew of new therapies patients with chronic lymphocytic leukemia (CLL) are seeing remissions and living longer. In our cover story, we discuss the Fortunate Turn of Events in CLL.

Next, with many blood cancers, blood transfusions are common. But how safe are they? Within the pages of this issue, we explain the technology that is boosting safety and Transforming Transfusions.

And, after learning to walk again following a life-changing multiple myeloma diagnosis, one man takes on the climb of a lifetime to help raise awareness and funding for the disease. Richard Bell shares his trip to Mount Washington as part of our Moving Mountains for Multiple Myeloma program in Small Steps, Big Dreams.

To read these stories and more, check out our full Hematology Special Issue online now. 

Or, ensure you don’t miss a story when you subscribe to new issue alerts.

And, as always, thanks for reading.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Myeloma CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In